Appili Therapeutics Inc.
APLIF
$0.026
-$0.002-7.14%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 456.50K | 292.50K | 393.10K | 1.82M | 1.05M |
| Total Receivables | 834.20K | 961.50K | 999.40K | 311.00K | 639.50K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 174.00K | 165.90K | 215.80K | 170.80K | 208.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.46M | 1.42M | 1.61M | 2.30M | 1.90M |
|
|
|||||
| Total Current Assets | 1.46M | 1.42M | 1.61M | 2.30M | 1.90M |
| Net Property, Plant & Equipment | 25.80K | 27.70K | 30.90K | 10.80K | 9.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.49M | 1.45M | 1.64M | 2.32M | 1.91M |
|
|
|||||
| Total Accounts Payable | 2.84M | 2.61M | 2.25M | 2.03M | 1.47M |
| Total Accrued Expenses | -- | 61.40K | 160.50K | 56.00K | 349.60K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 318.10K | 262.60K | 163.60K | 83.60K | 76.40K |
| Total Finance Division Other Current Liabilities | 29.50K | 24.40K | 39.70K | 30.30K | 25.20K |
| Total Other Current Liabilities | 29.50K | 24.40K | 39.70K | 30.30K | 25.20K |
| Total Current Liabilities | 3.19M | 2.96M | 2.62M | 2.20M | 1.93M |
|
|
|||||
| Total Current Liabilities | 3.19M | 2.96M | 2.62M | 2.20M | 1.93M |
| Long-Term Debt | 5.75M | 5.65M | 5.64M | 5.58M | 3.94M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.94M | 8.62M | 8.26M | 7.78M | 5.87M |
|
|
|||||
| Common Stock & APIC | 41.79M | 40.60M | 36.94M | 36.02M | 35.73M |
| Retained Earnings | -51.48M | -50.15M | -50.49M | -48.27M | -46.29M |
| Treasury Stock & Other | 2.25M | 2.38M | 6.93M | 6.78M | 6.60M |
| Total Common Equity | -7.44M | -7.17M | -6.62M | -5.47M | -3.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.44M | -7.17M | -6.62M | -5.47M | -3.96M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.44M | -7.17M | -6.62M | -5.47M | -3.96M |
|
|
|||||
